With the outbreak of the new version of Covid 19 in the United States, vaccines are under the continuous scrutiny of medical experts and researchers. It has been found that the initial two doses of the vaccines are not in favor of the people as the vaccines are losing their effectiveness with the passage of time and the medical authorities are now asking tough questions from the vaccine developers in the US.
CDC Will Be Conducting A Meeting Showed The Effects Of J&J Vaccine
Amidst several updates coming on coronavirus, the recent developments include the US Centers for Disease Control and Prevention’s vaccine advisers holding a meeting with Johnson & Johnson. The meet has been finalized in order to reanalyze the benefits and risks associated with the vaccine. As per the reports coming out, The Advisory Committee is all set to give their votes on “updated recommendations for use”.
The meeting has been finalized for Thursday over the issue of the increasing rate of blood clotting cases in the US. This problem has been raised after a study conducted and research showed that those who have received a single dose of the Johnson & Johnson vaccine are suffering from blood clot issues and 8 women have lost their lives due to blood clotting.
The US Food and Drug Administration has released some data and stated that these uncommon blood clot issues due to the J&J vaccine have been majorly found in women between 30 to 50 years of age.
Now it is up to the US Centers for Disease Control and Prevention whether to state new recommendations for the Johnson & Johnson vaccines as no such after-effects like blood clotting have been found in Pfizer and Moderna vaccines.
A single dose of the vaccine manufactured by Johnson & Johnson provides protection against coronavirus in people aged 18 years and above. It can be used in the form of booster shots for people who have been fully vaccinated after the mix-matching study conducted by the vaccine developer showed positive intent during the clinical trials.
Also, it has been advised that the people who have received a single dose of the vaccine of Johnson and Johnson at least 2 months ago can go ahead with taking the booster shot to fully protect themselves against the omicron variant.
According to the reports, as far as the meeting is concerned, the CDC Advisory panel has analyzed the results which will be further discussed with the officials of Johnson & Johnson. The J&J vaccine is known to be quite effective against the Covid 19 virus and also showed positive results when the delta variant started to infect people in the US but is also associated with risks that can lead to the development of diseases like thrombosis and thrombocytopenia, according to some medical experts who have been following the vaccine results for a long time. These are some of the rare blood clotting situations that J&J vaccines have been linked to and this issue is a matter of concern.
Dr. Rochelle Walensky, director of CDC did not make any comment on the purpose behind the meeting in a press briefing held at the White House on Wednesday. The meeting will involve reviewing the data associated with the vaccines and further recommendations will come after that. It might be possible that the authorities can refrain from the use of the Johnson and Johnson vaccine in women aged below 50 years if such types of issues take place.